CNR Institutional Research Information System

LUVISETTO, SIRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.221
NA - Nord America 2.506
EU - Europa 938
SA - Sud America 803
Continente sconosciuto - Info sul continente non disponibili 71
AF - Africa 66
OC - Oceania 6
Totale 8.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.369
SG - Singapore 1.692
CN - Cina 1.036
BR - Brasile 636
VN - Vietnam 444
HK - Hong Kong 368
IT - Italia 293
KR - Corea 233
FR - Francia 230
BD - Bangladesh 94
JP - Giappone 93
DE - Germania 88
NL - Olanda 78
IN - India 72
FI - Finlandia 58
GB - Regno Unito 55
CA - Canada 54
AR - Argentina 52
CO - Colombia 34
EC - Ecuador 30
ID - Indonesia 30
IL - Israele 28
MX - Messico 26
ES - Italia 23
ZA - Sudafrica 22
TR - Turchia 21
AT - Austria 18
CL - Cile 14
VE - Venezuela 13
IQ - Iraq 12
PK - Pakistan 12
PL - Polonia 12
RU - Federazione Russa 12
MA - Marocco 11
CR - Costa Rica 10
HN - Honduras 10
PE - Perù 10
UZ - Uzbekistan 10
IE - Irlanda 9
PY - Paraguay 9
SA - Arabia Saudita 9
SE - Svezia 9
UA - Ucraina 9
EG - Egitto 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
JM - Giamaica 7
KE - Kenya 7
MY - Malesia 7
PH - Filippine 7
TH - Thailandia 7
KZ - Kazakistan 6
TN - Tunisia 6
LB - Libano 5
TT - Trinidad e Tobago 5
AL - Albania 4
AU - Australia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KH - Cambogia 4
SI - Slovenia 4
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
GR - Grecia 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
SV - El Salvador 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
CH - Svizzera 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
GA - Gabon 1
GP - Guadalupe 1
HU - Ungheria 1
IR - Iran 1
Totale 8.526
Salva come PNG Salva come JPEG
Città #
Singapore 1.022
Santa Clara 597
Hefei 520
Hong Kong 360
San Jose 283
Seoul 228
Lauterbourg 198
Ho Chi Minh City 160
Ashburn 156
Beijing 155
Dallas 128
Hanoi 85
Rome 83
Los Angeles 77
São Paulo 61
Tokyo 61
Helsinki 44
New York 35
Frankfurt am Main 32
Minamishinagawa 29
Buffalo 26
Bengaluru 24
Atlanta 22
Milan 22
Council Bluffs 19
Da Nang 18
Haiphong 17
Boardman 16
Hải Dương 16
Orem 16
Dhaka 15
London 15
Rio de Janeiro 15
Belo Horizonte 14
Brooklyn 14
Chicago 14
Nuremberg 14
Philadelphia 14
Vienna 14
Amsterdam 13
Biên Hòa 13
Düsseldorf 13
Johannesburg 12
Warsaw 12
Brasília 11
Chennai 11
Bogotá 10
Boston 10
Guangzhou 10
Guayaquil 10
Montreal 10
Orvieto 10
Tashkent 10
Campinas 9
Can Tho 9
Curitiba 9
Falkenstein 9
Houston 9
Paris 9
Phoenix 9
Quito 9
San Antonio 9
Naples 8
Ninh Bình 8
Portsmouth 8
San José 8
Thái Nguyên 8
Toronto 8
Cabo Frio 7
Cairo 7
Charlotte 7
Denver 7
Dublin 7
Goiânia 7
Guarulhos 7
Lappeenranta 7
Miami 7
Munich 7
Nairobi 7
Ribeirão Preto 7
Salvador 7
San Francisco 7
Shanghai 7
The Bronx 7
Buenos Aires 6
Bắc Giang 6
Columbus 6
Lima 6
Madrid 6
Medellín 6
New Delhi 6
Newark 6
Porto Alegre 6
Sorocaba 6
Stockholm 6
São Gonçalo 6
Bari 5
Bologna 5
Brescia 5
Bắc Ninh 5
Totale 5.127
Salva come PNG Salva come JPEG
Nome #
2023Pdm3 March 30 - Abstract 47 Estrogens recover muscle regeneration impaired by the pathogenic gene, DUX4, in orthotopic human xenograft 125
Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice. 118
SNAP25 CLEAVAGE BY BOTULINUM NEUROTOXIN-A REPROGRAMS SCHWANN CELLS INTO A PROREGENERATIVE PHENOTYPE 113
Pharmacological Interaction of Botulinum Neurotoxins with Excitatory and Inhibitory Neurotransmitter Systems Involved in the Modulation of Inflammatory Pain 105
Lack of cyclin D3 induces skeletal muscle fiber-type shifting, increased endurance performance and hypermetabolism 104
Botulinum Neurotoxins beyond Neurons: Interplay with Glial Cells 100
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy 98
Effects of age-related loss of P/Q-type calcium channels in a mice model of peripheral nerve injury 97
BoNT-A as a Possible Treatment fo Chronic Spinal Cord Injury 96
Analgesic effects of botulinum neurotoxin type A in a model of allyl isothiocyanate- and capsaicin-induced pain in mice 95
Promising therapeutic applications of botulinum neurotoxins: nerve regeneration and functional recovery in a spinal cord injury mouse model. 95
Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy 94
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model 89
Pain-related behaviours in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 86
EFFECTS OF BOTULINUM NEUROTOXIN TYPE B IN NEUROPATHIC MICE: BEHAVIORAL AND IMMUNOHISTOCHEMICAL INVESTIGATIONS 85
Botulinum toxin type a as a therapeutic agent against headache and related disorders 85
Study of regenerative potential of human perivascular cells expressing DUX4 82
Central injection of botulinum neurotoxins: toxicology, brain localization and bahavioural effects in mice 81
The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors 80
Estrogenic hormones counteract FSHD features in a mouse model of muscle regeneration. 80
Botulinum Toxins: New Uses in the Treatment of Diseases 80
Xeomin((R)), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury 79
Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse model 78
Local protons and uncoupling of aerobic and artificial ???H-driven ATP synthesis 76
Cyclin D3 deficiency promotes a slower, more oxidative skeletal muscle phenotype and ameliorates pathophysiology in the mdx mouse model of Duchenne muscular dystrophy 76
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice 75
Altered pain sensitivity in mice lacking the CaV2.1alpha1 subunit of P/Q-type Ca2+ channels 71
Experimental gene therapy of Duchenne Muscular Dystrophy by artificial transcription factors upregulating the dystrophin-related gene Utrophin 70
Re-programming utrophin gene expression in DMD using artificial transcription factors 69
Proton leaks, pump slips and hyperthyroidism. 68
Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1. 67
PERMEABILITY OF THE INNER MITOCHONDRIAL MEMBRANE AND RESPIRATION 66
Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice. 66
Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain 65
Central injection of botulinum neurotoxins: behavioural effects in mice. 64
The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord 64
The role of glial cells in the experience of pain: how much is important the sex factor? 64
Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications. 63
Habit learning in the cross maze: a cross talk between the context and the goal for action control. 62
Nuova applicazione terapeutica della neurotossina botulinica sierotipo A 62
Modulatory action of botulinum toxin type A on neuropathic pain: behavioral and immunohistochemical studies in animal models 60
Single channel biophysical properties of wild-type and mutant human P/Q-type calcium channels. 60
Tracking of proton flow during transition from anaerobiosis to static head in rat liver mitochondria. 59
The influence of BoNT/A administration on IL-1 family members in rat neuropathic pain model - in vivo and in vitro evidences. 57
Przeciwbólowe efekty toksyny botulinowej A w szczurzym modelu bólu neuropatycznego. 57
17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice. 57
Sex differences and modulatory effect of 17beta-estradiol on behavioral and immune responses in neuropathic mice. 55
Botulinum Neurotoxins and Nervous System: Future Challenges for Novel Indications 55
Experimental gene therapy of Duchenne Muscular Dystrophy by artificial transcription factors upregulating the dystrophin-related gene Utrophin 55
A new clinical relevant murine model of spinal cord injury mimicking the pathological features of complete paralysis in humans. 54
Botulinum toxin and neuronal regeneration after traumatic injury of central and peripheral nervous system 54
Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. 53
Higher pain perception and lack of recovery from neuropathic pain in females: A behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice 53
Introduction to the Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases 52
Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers 52
Esano e suoi derivati: disaccoppiamento della catena respiratoria mitocondriale. 51
Free energy coupling: from phases to molecules. 51
Novel Adeno-Associated Viral Vector Delivering the Utrophin Gene Regulator Jazz Counteracts Dystrophic Pathology in mdx Mice 51
Rac-dependent pathway and cytoskeleton remodeling: a newintracellular mechanism for modulation of inflammatory pain 50
Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by beta subunits. 50
Pathways implicated in tadalafil amelioration of Duchenne Muscular Dystrophy 48
COMPOSITION AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY (US10301367B2) 48
CNF1 BACTERIAL TOXIN PROTEIN FROM E. COLI AS ANALGESIC 47
Cognitive and neural determinants of response strategy in the dual-solution plus-maze task 47
Altered sensitivity to nociceptive stimuli in mice lacking the CaV2.1 alpha1 subunit of P/Q-type Ca2+ channels. 46
COMPOSITION AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY (EP3194600B1) 46
Effects of Botulinum Toxin on Functional Recovery after Injures of Nervous System 45
Disaccoppiamento della fosforilazione ossidativa indotto da FCCP, cloroformio e acido oleico in rat liver mitochondria 44
The nature of uncoupling by n-hexane, 1-hexanethiol and 1-hexanol in rat liver mitochondria 44
Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. 44
Tyr682 in the Abeta-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance 44
Remission of hair loss and induction of hair regrowth by botulinum neurotoxin A in mice 43
Botulinum neurotoxin serotype A: an innovative pharmacological approach for pain treatment. 43
Botulinum neurotoxin serotype A improves behavioural responses and peripheral nerve regeneration in a mouse model of neuropathic pain 43
Modulatory action of botulinum toxin type A on neuropathic pain; insights from animal models. 42
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. 42
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes 42
Introduction to Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases (2nd Edition) 41
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice 40
PH dependence of human CaV2.1 channels and its alteration by a familial hemiplegic migraine mutation. 40
Is the retrograde transport of botulinum neurotoxin type A involved in its analgesic effects on neuropathic pain? 38
Central injection of botulinum neurotoxins: toxicology and behavioural effects in mice 37
ANIMAL MODELS TO VALIDATE THE USE OF NEW SMALL SYNTHETIC TRANSCRIPTION FACTORS IN THE GENE THERAPY OF MUSCLE DYSTROPHIES 37
Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by β subunits 37
Utrophin up-regulation mediated by an artificial transcription factor ameliorates the dystrophic symptoms in mdx mice. 36
Modal gating of human Cav2.1 (P/Q-type) calcium channels. II. The b mode and reversible uncoupling of inactivation 36
Toxicological and behavioural effects of botulinum neurotoxins injected in central nervous system 36
Altered sensitivity to nociception stimuli in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 36
Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D 35
pH dependence of human CaV2.1 channels and its alteration by a familial hemiplegic migraine mutation 35
Nature of respiratory stimulation in hyperthyroidism: the redox behaviour of cytochrome c 34
Anomalous L-type calcium channels of rat spinal motoneurons 34
Toxicity of botulinum neurotoxins in central nervous system of mice 33
THE REDOX STATE OF CYTOCHROMES AS A NEW TOOL TO ASSESS THE THERMODYNAMIC STATE OF MITOCHONDRIA 33
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. 32
Familial hemiplegic migraine mutations increase Ca2+ influx through single human Cay2.1 channels and decrease maximal Cay2.1 current density in neurons. 32
Botulinum neurotoxin serotype A and morphine: a successful pharmacological combination for treating inflammatory pain 32
The distinction between leaks and slips. 32
The mechanism of uncoupling of oxidative phosphorylation. 32
Morphine and botulinum neurotoxin A: a successful pharmacological combination against pain? 32
Totale 5.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.802
article - articoli 13.559
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 894
Totale 42.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202484 0 0 0 0 0 0 0 0 6 3 58 17
2024/20252.697 15 13 202 124 526 122 37 120 64 103 711 660
2025/20265.035 268 688 579 751 811 159 743 238 232 255 116 195
2026/2027795 265 216 314 0 0 0 0 0 0 0 0 0
Totale 8.611